Jump to content

Crystal Denlinger

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by InternetArchiveBot (talk | contribs) at 20:45, 1 October 2022 (Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.9.2). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Crystal Denlinger
Born1975 (age 48–49)[notes 1]
New Jersey, US
Academic background
EducationMD, 2001, New Jersey Medical School
Academic work
InstitutionsNational Comprehensive Cancer Network
Fox Chase Cancer Center

Crystal Denlinger (born 1975) is an American medical oncologist. In 2021, she was appointed the Chief Scientific Officer of the National Comprehensive Cancer Network.

Early life and education

Denlinger was born to parents Edgar and Cynthia in New Jersey[2] and grew up alongside her brother Craig.[3] She obtained her medical degree from New Jersey Medical School and completed her internal medicine residency at Mount Sinai Medical Center. Following this, she completed her fellowship in hematology/oncology at Temple University's Fox Chase Cancer Center.[4] Denlinger later said that she chose to pursue a career in oncology after her father was diagnosed with kidney cancer.[2]

Career

Upon completing her formal education, Denlinger joined the faculty at Fox Chase Cancer Center. While serving as an associate professor, Denlinger became a founding member of the National Comprehensive Cancer Network (NCCN)'s Survivorship Guideline panel and spearheaded the development of the Center for Survivorship at Fox Chase.[5]

While flying to the NCCN's 19th Annual Conference in March 2014, Denlinger's plane crashed on the runway following takeoff. She bordered another flight six hours later to reach the conference in time.[1] At the conference, Denlinger presented with Terry S. Langbaum on the topic of patients and providers' care and surveillance following cancer.[6] She was originally scheduled to present a poster study but left that on the plane when she was evacuated.[7] A few years later, Denlinger became the first and only NCCN Panel chair who began her relationship with NCCN as a participant in the NCCN Fellows Program. In 2018, her efforts were honored by the NCCN with their Rodger Winn Award.[8]

During the COVID-19 pandemic, Denlinger was named the Chief Scientific Officer for National Comprehensive Cancer Network.[9]

Notes

  1. ^ In 2014, Denlinger was reported to be 38[1]

References

  1. ^ a b Mulcahy, Nick (March 14, 2014). "Oncologist Survives Plane Crash, Gives NCCN Talk". Medscape. Archived from the original on June 10, 2021. Retrieved June 7, 2021.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
  2. ^ a b "A NEW PERSPECTIVE ON MEDICINE" (PDF). Temple University. 2014. pp. 14–15. Retrieved June 7, 2021.
  3. ^ "Edgar J. Denlinger". Retrieved June 7, 2021.
  4. ^ "Crystal S. Denlinger, MD, FACP". Fox Chase Cancer Center. Retrieved June 7, 2021.
  5. ^ "Fox Chase Cancer Center Leads Efforts to Establish National Standards for Survivorship Care". Fox Chase Cancer Center. March 18, 2012. Retrieved June 7, 2021.
  6. ^ Caffrey, Mary K. (May 15, 2014). "Denlinger Discusses Posttreatment Surveillance for Cancer Survivors". American Journal of Managed Care. Retrieved June 7, 2021.
  7. ^ Susman, Ed (April 25, 2014). "NCCN Speaker Doesn't Let Plane Crash Stop Her Presentation". Oncology Times. 36 (8): 10. doi:10.1097/01.COT.0000446669.86390.2a. Retrieved June 7, 2021.
  8. ^ "National Comprehensive Cancer Network Honors Key Contributors to the Improvement of Global Cancer Care and Dedication to the NCCN Mission". Newswire. March 29, 2018. Retrieved June 7, 2021.
  9. ^ "Crystal Denlinger Named Chief Scientific Officer for National Comprehensive Cancer Network". Newswire. January 14, 2021. Retrieved June 7, 2021.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Crystal_Denlinger&oldid=1113506684"